TABLE 4.
HPV positivity | Crude OR (95% CI) | P value | Adjusted ORa (95% CI) | P valueb |
---|---|---|---|---|
Any α-HPV | ||||
HPV− | 1 | 1 | ||
HPV+ | 0.4 (0.1 to 1.2) | 0.112 | 0.40 (0.1 to 1.2) | 0.111 |
Any β-HPV | ||||
HPV− | 1 | 1 | ||
HPV+ | 1.2 (0.9 to 1.7) | 0.179 | 1.18 (0.9 to 1.6) | 0.299 |
Types associated with disease | ||||
HPV100 | 2.6 (0.9 to 7.8) | 0.079 | 2.75 (0.9 to 8.2) | 0.070 |
HPV111 | 0.5 (0.2 to 1.1) | 0.089 | 0.5 (0.2 to 1.2) | 0.116 |
HPV124 | 0.6 (0.3 to 1.1) | 0.081 | 0.5 (0.3 to 1.0) | 0.061 |
HPV174 | 3.4 (0.98 to 11.4) | 0.053 | 3.1 (0.9 to 10.6) | 0.073 |
Any γ-HPV | ||||
HPV− | 1 | 1 | ||
HPV+ | 1.1 (0.8 to 1.5) | 0.688 | 1.0 (0.7 to 1.5) | 0.830 |
Types associated with disease | ||||
HPV95 | zero HPV95 in controls | -c | - | - |
HPV123 | zero HPV95 in controls | - | - | - |
HPV134 | 0.4 (0.2 to 0.96) | 0.042 | 0.42 (0.2 to 0.96) | 0.041 |
HPV168 | 0.19 (0.0 to 0.99) | 0.049 | 0.18 (0.0 to 0.98) | 0.048 |
ORs were adjusted for age (10-year intervals), gender, place of residence, tobacco use, opium use, and socioeconomic status.
Italic p values indicate positive trends. Bold p values indicate a significant association.
Due to zero number, it was not possible to estimate ORs and 95% CIs.